Shanghai Sanyou Medical Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 7.69%

Shanghai Sanyou Medical Co Ltd (688085) has an Asset Resilience Ratio of 7.69% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Shanghai Sanyou Medical Co Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥180.23 Million
≈ $26.37 Million USD Cash + Short-term Investments

Total Assets

CN¥2.34 Billion
≈ $343.00 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2020–2024)

This chart shows how Shanghai Sanyou Medical Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of Shanghai Sanyou Medical Co Ltd.

Liquid Assets Composition Over Time

This chart breaks down Shanghai Sanyou Medical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read how much debt does Shanghai Sanyou Medical Co Ltd carry for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥180.23 Million 7.69%
Total Liquid Assets CN¥180.23 Million 7.69%

Asset Resilience Insights

  • Limited Liquidity: Shanghai Sanyou Medical Co Ltd maintains only 7.69% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Shanghai Sanyou Medical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Shanghai Sanyou Medical Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Cochlear Ltd
AU:COH
Medical Devices 9.76%
L&C Bio Co. Ltd
KQ:290650
Medical Devices 2.14%
Eurobio Scientific SA
PA:ALERS
Medical Devices 10.52%
Profound Medical Corp
TO:PRN
Medical Devices 67.66%
EBR Systems Inc
AU:EBR
Medical Devices 54.70%
Epitomee Medical Ltd
TA:EPIT
Medical Devices 0.24%
Cleo Diagnostics Ltd
AU:COV
Medical Devices 94.64%
Aligned Genetics Inc
KQ:238120
Medical Devices 2.22%

Annual Asset Resilience Ratio for Shanghai Sanyou Medical Co Ltd (2020–2024)

The table below shows the annual Asset Resilience Ratio data for Shanghai Sanyou Medical Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 2.18% CN¥50.23 Million
≈ $7.35 Million
CN¥2.31 Billion
≈ $337.54 Million
+1.31pp
2023-12-31 0.87% CN¥19.63 Million
≈ $2.87 Million
CN¥2.26 Billion
≈ $330.93 Million
-7.94pp
2022-12-31 8.81% CN¥193.10 Million
≈ $28.26 Million
CN¥2.19 Billion
≈ $320.67 Million
-10.05pp
2021-12-31 18.86% CN¥376.63 Million
≈ $55.11 Million
CN¥2.00 Billion
≈ $292.25 Million
-33.85pp
2020-12-31 52.71% CN¥880.65 Million
≈ $128.87 Million
CN¥1.67 Billion
≈ $244.47 Million
--
pp = percentage points

About Shanghai Sanyou Medical Co Ltd

SHG:688085 China Medical Devices
Market Cap
$641.18 Million
CN¥4.38 Billion CNY
Market Cap Rank
#11135 Global
#3131 in China
Share Price
CN¥13.14
Change (1 day)
+2.66%
52-Week Range
CN¥11.41 - CN¥23.21
All Time High
CN¥70.68
About

Shanghai Sanyou Medical Co., Ltd. researches, develops, manufactures, and sells orthopedics implants in China. The company offers spinal and trauma implants under Tytus and Sanyou brand. Its spinal products comprise anterior cervical plate, anterior thoracolumbar, posterior cervical, posterior thoracolumbar, and minimally invasive products; and trauma implants, including shoulder and elbow system… Read more